GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Tri Prime Gene Pharmaceutical Co Ltd (BJSE:837344) » Definitions » Selling, General, & Admin. Expense

Beijing Tri Prime Gene Pharmaceutical Co (BJSE:837344) Selling, General, & Admin. Expense : ¥106.6 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Beijing Tri Prime Gene Pharmaceutical Co Selling, General, & Admin. Expense?

Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. Beijing Tri Prime Gene Pharmaceutical Co's selling, general, & admin. expense for the three months ended in Sep. 2024 was ¥56.2 Mil. Its selling, general, & admin. expense for the trailing twelve months (TTM) ended in Sep. 2024 was ¥106.6 Mil.


Beijing Tri Prime Gene Pharmaceutical Co Selling, General, & Admin. Expense Historical Data

The historical data trend for Beijing Tri Prime Gene Pharmaceutical Co's Selling, General, & Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Tri Prime Gene Pharmaceutical Co Selling, General, & Admin. Expense Chart

Beijing Tri Prime Gene Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Selling, General, & Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 108.34 69.65 80.26 69.17 101.00

Beijing Tri Prime Gene Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Selling, General, & Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 53.61 2.58 32.34 15.44 56.22

Competitive Comparison of Beijing Tri Prime Gene Pharmaceutical Co's Selling, General, & Admin. Expense

For the Biotechnology subindustry, Beijing Tri Prime Gene Pharmaceutical Co's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Tri Prime Gene Pharmaceutical Co's Selling, General, & Admin. Expense Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Beijing Tri Prime Gene Pharmaceutical Co's Selling, General, & Admin. Expense distribution charts can be found below:

* The bar in red indicates where Beijing Tri Prime Gene Pharmaceutical Co's Selling, General, & Admin. Expense falls into.



Beijing Tri Prime Gene Pharmaceutical Co Selling, General, & Admin. Expense Calculation

Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.

Selling, General, & Admin. Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥106.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Tri Prime Gene Pharmaceutical Co  (BJSE:837344) Selling, General, & Admin. Expense Explanation

An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.

Warren Buffett likes companies with consistent SGA as the percentage of gross profit.

Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.

If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.


Beijing Tri Prime Gene Pharmaceutical Co Selling, General, & Admin. Expense Related Terms

Thank you for viewing the detailed overview of Beijing Tri Prime Gene Pharmaceutical Co's Selling, General, & Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Tri Prime Gene Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 1, Jinyuan Road, Building 4, Daxing Economic Development Zone, Daxing District, Beijing, CHN, 102600
Beijing Tri Prime Gene Pharmaceutical Co Ltd is mainly engaged in the research, development, production, and sales of medical biotechnology products including genetic engineering drugs, genetic engineering vaccines, and diagnostic reagents, and engaged in related technical trade and technical consulting services. Its product line comprises Yundex Spray, Yundex Eye Drops, Yundexol Powder Injection, Yundexol Water Injection.

Beijing Tri Prime Gene Pharmaceutical Co Headlines

No Headlines